These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31705514)

  • 21. From isoniazid to psychobiotics: the gut microbiome as a new antidepressant target.
    Butler MI; Sandhu K; Cryan JF; Dinan TG
    Br J Hosp Med (Lond); 2019 Mar; 80(3):139-145. PubMed ID: 30860919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial neuroactive compounds produced by psychobiotics.
    Wall R; Cryan JF; Ross RP; Fitzgerald GF; Dinan TG; Stanton C
    Adv Exp Med Biol; 2014; 817():221-39. PubMed ID: 24997036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Co-Metabolism within the Gut-Brain Metabolic Interaction: Potential Targets for Drug Treatment and Design.
    Obrenovich M; Flückiger R; Sykes L; Donskey C
    CNS Neurol Disord Drug Targets; 2016; 15(2):127-34. PubMed ID: 26831263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychobiotics: An emerging probiotic in psychiatric practice.
    Kali A
    Biomed J; 2016 Jun; 39(3):223-4. PubMed ID: 27621125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders.
    Cheng LH; Liu YW; Wu CC; Wang S; Tsai YC
    J Food Drug Anal; 2019 Jul; 27(3):632-648. PubMed ID: 31324280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature.
    Milosevic I; Vujovic A; Barac A; Djelic M; Korac M; Radovanovic Spurnic A; Gmizic I; Stevanovic O; Djordjevic V; Lekic N; Russo E; Amedei A
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delivery to the gut microbiota: A rapidly proliferating research field.
    Seifert A; Kashi Y; Livney YD
    Adv Colloid Interface Sci; 2019 Dec; 274():102038. PubMed ID: 31683191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychobiotics: Shaping the Mind With Gut Bacteria.
    Jacobs JP; Mayer EA
    Am J Gastroenterol; 2019 Jul; 114(7):1034-1035. PubMed ID: 31268916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Foreword: all things considered about probiotics, prebiotics and ıntestinal microbiota in children - from bench to bedside.
    Ozen M; Dinleyici EC
    Benef Microbes; 2015; 6(2):153-7. PubMed ID: 25851100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Approach of probiotics in mental health as a psychobiotics.
    Sharma H; Bajwa J
    Arch Microbiol; 2021 Dec; 204(1):30. PubMed ID: 34923592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Microbiome-Gut-Brain Axis in Health and Disease.
    Dinan TG; Cryan JF
    Gastroenterol Clin North Am; 2017 Mar; 46(1):77-89. PubMed ID: 28164854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Narrative Review of Psychobiotics: Probiotics That Influence the Gut-Brain Axis.
    Ķimse L; Reinis A; Miķelsone-Jansone L; Gintere S; Krūmiņa A
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychobiotics: A new approach for treating mental illness?
    Misra S; Mohanty D
    Crit Rev Food Sci Nutr; 2019; 59(8):1230-1236. PubMed ID: 29190117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychobiotics and the Microbiota-Gut-Brain Axis: Where Do We Go from Here?
    Binda S; Tremblay A; Iqbal UH; Kassem O; Le Barz M; Thomas V; Bronner S; Perrot T; Ismail N; Parker JA
    Microorganisms; 2024 Mar; 12(4):. PubMed ID: 38674579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Intestinal Microbiota and Irritable Bowel Syndrome.
    Ringel Y; Ringel-Kulka T
    J Clin Gastroenterol; 2015; 49 Suppl 1():S56-9. PubMed ID: 26447966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of gut microbiota in chronic liver diseases, and treatment possibilities].
    Hagymási K; Bacsárdi A; Egresi A; Berta E; Tulassay Z; Lengyel G
    Orv Hetil; 2018 Sep; 159(36):1465-1474. PubMed ID: 30175608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic interplay between gut bacteria and their host.
    Duca F; Gérard P; Covasa M; Lepage P
    Front Horm Res; 2014; 42():73-82. PubMed ID: 24732926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.
    Briskey D; Tucker P; Johnson DW; Coombes JS
    Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.